We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Systems Biology Used To Study Cellular Glycomics in White Blood Cells

By LabMedica International staff writers
Posted on 12 Nov 2008
Print article
Two recent papers have presented the results of attempts to use a systems biology approach to understand the cellular glycome. The glycome represents a cell's total sugar or carbohydrate composition. It has been described as exceeding the complexity of the proteome because of the even greater diversity of the glycome's constituent carbohydrates, and is further complicated by the sheer multiplicity of possibilities in the combination and interaction of the carbohydrates with each other and with proteins.

Systems biology is a mathematical and experimental approach that focuses on whole systems of complex biological functions and interactions instead of studying individual units, such as a single gene or protein, in isolation. Investigators at the University at Buffalo (NY, USA) used this approach to examine the relationship between gene expression, glycosyltransferase activity, glycan expression, and selectin-binding function in different cell systems, including human neutrophils, undifferentiated HL-60 (human promyelocytic cells), differentiated HL-60, and HL-60 synchronized in specific growth phases. Selectins are a large family of membrane proteins that bind oligosaccharides on other cells tightly and specifically, and are involved in signal transduction across the plasma membrane.

Their results were published in two papers. The first article, which appeared in the August 26, 2008, online edition of The FASEB Journal, described the experimental techniques used to measure enzyme reaction rates involved in glycosylation, and then drew critical correlations with gene expression, enzyme kinetics, and the structures of glycans. The second paper, which was published in the October 7, 2008, online edition of the journal Bioinformatics, described a computer model that utilized the data produced by those experiments to establish a basis for predicting the structures of glycans on cell surfaces.

"Our goal is to find ways to alter carbohydrate structures or glycans on the surfaces of white blood cells,” explained senior author Dr. Sriram Neelamegham, professor of chemical and biological engineering at the University of Buffalo. "Systems biology is well suited to this research because it helps us develop the mathematical concepts to enable us to influence and enhance our understanding of how the glycome functions. This then produces clues on how we might manipulate the adhesivity of white blood cells to the blood vessel wall.”

"The data produced experimentally allows us to determine key steps in the glycome reaction network that controls the final glycan structure that appears on cells,” said Dr. Neelamegham. "This approach then provides an in silico tool that can be applied to perturb the system of interest, such as the glycosylation network.”

Related Links:
State University of New York, University at Buffalo

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TETANUS Test
TETANUS VIRCLIA IgG MONOTEST
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.